The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 7, Issue 1, Pages 49-62
Publisher
Informa Healthcare
Online
2010-11-23
DOI
10.1517/17425255.2011.538383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The ABCG2 resistance network of glioblastoma
- (2011) Anne-Marie Bleau et al. CELL CYCLE
- Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters
- (2010) J. Weiss et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction
- (2010) Kristian M. Bailey et al. Circulation-Cardiovascular Genetics
- ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin
- (2010) B Tomlinson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Efflux and uptake transporters as determinants of statin response
- (2010) Alice C Rodrigues Expert Opinion on Drug Metabolism & Toxicology
- Aryl Hydrocarbon Receptor Is a Transcriptional Activator of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
- (2010) K. P. Tan et al. MOLECULAR PHARMACOLOGY
- The effects of cholesterol on learning and memory
- (2010) Bernard G. Schreurs NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Effects of Three Strong Statins (Atorvastatin, Pitavastatin, and Rosuvastatin) on Serum Uric Acid Levels in Dyslipidemic Patients
- (2010) N. Ogata et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients
- (2010) Miao Hu et al. Pharmacogenetics and Genomics
- Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER)
- (2009) Stephen J. Nicholls et al. AMERICAN JOURNAL OF CARDIOLOGY
- No significant effect ofABCB1haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin
- (2009) Jenni E. Keskitalo et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Transporter Pharmacogenetics and Statin Toxicity
- (2009) M Niemi CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells
- (2009) Daisuke Yamasaki et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
- (2009) Ichiro Ieiri et al. Expert Opinion on Drug Metabolism & Toxicology
- Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population
- (2009) Binbin Wang et al. HUMAN GENETICS
- ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood-Brain Barrier for A 1-40 Peptides
- (2009) H. Xiong et al. JOURNAL OF NEUROSCIENCE
- Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2
- (2009) K. K.W. To et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells
- (2009) Y.-Z. Pan et al. MOLECULAR PHARMACOLOGY
- Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants
- (2009) Sekar Kathiresan et al. NATURE GENETICS
- Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs
- (2009) Alice Cristina Rodrigues et al. PHARMACOGENOMICS
- Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin
- (2009) Jenni E Keskitalo et al. PHARMACOGENOMICS
- APOE gene polymorphisms and response to statin therapy
- (2009) E Zintzaras et al. PHARMACOGENOMICS JOURNAL
- Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays
- (2008) Csilla Hegedűs et al. ADVANCED DRUG DELIVERY REVIEWS
- ABCG2: A perspective
- (2008) Robert W. Robey et al. ADVANCED DRUG DELIVERY REVIEWS
- The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis
- (2008) A. Blum et al. ATHEROSCLEROSIS
- ABCG2 Expression and Side Population Abundance Regulated by a Transforming Growth Factor -Directed Epithelial-Mesenchymal Transition
- (2008) L. Yin et al. CANCER RESEARCH
- Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment
- (2008) Ronald M. Krauss et al. CIRCULATION
- ABCB1 Haplotypes Differentially Affect the Pharmacokinetics of the Acid and Lactone Forms of Simvastatin and Atorvastatin
- (2008) JE Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin
- (2008) S. Kitamura et al. DRUG METABOLISM AND DISPOSITION
- Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes
- (2008) Barbara V. Howard JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MicroRNAs play a role in the development of human hematopoietic stem cells
- (2008) Rongxia Liao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study
- (2008) Abbas Dehghan et al. LANCET
- Regulation of ABCG2 Expression at the 3' Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line
- (2008) K. K. W. To et al. MOLECULAR AND CELLULAR BIOLOGY
- Uric Acid and Cardiovascular Risk
- (2008) Daniel I. Feig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Silymarin Supplement on the Pharmacokinetics of Rosuvastatin
- (2008) Jian Wei Deng et al. PHARMACEUTICAL RESEARCH
- Pharmacogenomic importance of ABCG2
- (2008) George Cusatis et al. PHARMACOGENOMICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started